Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nonprofits Open Windows To Medtech Procedure, Device Costs

This article was originally published in The Gray Sheet

Executive Summary

Health care cost transparency websites like Guroo.com and ECRI’s Technology Price Index are intended to make it easier, respectively, for consumers to shop for health services and for hospitals to benchmark prices of medical supplies.

You may also be interested in...



Executive Order Gives HHS Power To Disclose True Device, Procedure Costs To Patients

Despite industry opposition, President Trump signed a cost transparency executive order giving HHS the regulatory power to reveal to the public, health-care facilities’ costs of devices and procedures.

Health Policy Spotlight: Telehealth Expands Access, But Might Increase Employer Costs, Study Finds

The increased convenience and lower costs of using telehealth to replace face-to-face doctor visits is likely to increase access to health care, but may also increase overall spending by tapping into an unmet need, a new study concludes. Also, a look at the impacts from reference pricing.

Epizyme’s Tazverik Gets To Market In Rare Sarcoma, Paving Way To Bigger Indications

Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.

Topics

UsernamePublicRestriction

Register

MT033705

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel